Demise of beta integrin inhibitor
XOMA and Millennium Pharmaceuticals have abandoned the development of MLN2201, a compound designed to inhibit vascular inflammation.
Archives for October 9, 2003
Amersham: Its General Electric
General Electric is the company offering to buy Amersham of the UK, it was confirmed today. The US group is offering £5.7 billion for the life sciences group, and said it has no plans to hive off Biosciences.
SNP database goes public
Affymetrix releases into the public domain what it says is the first significant SNP database that includes genotype data and allele frequencies across the entire human genome.